Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy

Rituximab (RTX) is an effective treatment for pemphigus; however, the drug labeling recommends not to use RTX within 1 year before conception. OBJECTIVES: To report pregnancy outcomes of patients with pemphigus who were treated with RTX before or during pregnancy. METHODS: We identified 19 pregnanci...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehghanimahmoudabadi, Azin, Kianfar, Nika, Akhdar, Marwa, Dasdar, Shayan, Balighi, Kamran, Mahmoudi, Hamidreza, Daneshpazhooh, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276145/
https://www.ncbi.nlm.nih.gov/pubmed/35837335
http://dx.doi.org/10.1097/JW9.0000000000000038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276145/
https://www.ncbi.nlm.nih.gov/pubmed/35837335
http://dx.doi.org/10.1097/JW9.0000000000000038

Ejemplares similares